# Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum

> **NCT03360760** · NA · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Osteosarcoma of Pelvis

## Interventions

- **DRUG:** Doxorubicin
- **DRUG:** Cisplatin
- **DRUG:** Methotrexate
- **DRUG:** Ifosfamide
- **PROCEDURE:** definitive surgery
- **OTHER:** pre surgical chemotherapy

## Key facts

- **NCT ID:** NCT03360760
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2020-02
- **Final completion:** 2025-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03360760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03360760, "Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03360760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*